Electronic State Business Daily Search

Sign in is NOT required.
For instructions on submitting bid responses, please review the posting entity’s solicitation and attached bid documents.

RFP for Opioid Use Disorder Treatment Medications

Solicitation ID: R2270-2023-7

Status: Addendum Posted

Contact Name: Brody Ballard

Contact Number: 512-440-4022

Contact Email: Brody.Ballard@Integralcare.org

Response Due Time: 5:00 PM

Agency/Texas SmartBuy Member Number: R2270

Days Solicited: 21+ Days for Solicitation Notice

Solicitation Posting Date: 11/14/2023

Response Due Date: 12/19/2023

Last Modified: 11/14/2023 2:48 pm

Solicitation Description:

Integral Care is soliciting proposals for SALE OF OPOIOD USE DISORDER TREATMENT MEDICATIONS (INCLUDING METHADONE, BUPRENORPHINE AND BUPRENORPHINE/NALOXONE). The Request for Proposals may be accessed beginning November 14, 2023. The deadline to submit a proposal under the RFP is 5:00 p.m. CDT on December 19, 2023. Historically Underutilized Businesses, including Minority-Owned Businesses and Women-Owned Businesses, are encouraged to apply.

Class/Item Code(s): 26972-Miscellaneous Drugs And Pharmaceuticals (Not Otherwise Classified)
26987-Therapeutic Agents, Unclassified


1ESBD_File_341623_RFP - Opioid Products (11-14-23).docxRFP Specifications